PRX-08066 (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "PRX-08066" in Serbian language version.

refsWebsite

Global rank Serbian rank

4^th place

8^th place

2^nd place

4^th place

6^th place

5^th place

archive.org (Global: 6^th place; Serbian: 5^th place)

Porvasnik SL, Germain S, Embury J, Gannon KS, Jacques V, Murray J, Byrne BJ, Shacham S, Al-Mousily F (2010). „PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats”. The Journal of Pharmacology and Experimental Therapeutics. 334 (2): 364—72. PMID 20430844. doi:10.1124/jpet.109.165001.
Svejda B, Kidd M, Giovinazzo F, Eltawil K, Gustafsson BI, Pfragner R, Modlin IM (2010). „The 5-HT(2B) receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment”. Cancer. 116 (12): 2902—12. PMID 20564397. doi:10.1002/cncr.25049.

Porvasnik SL, Germain S, Embury J, Gannon KS, Jacques V, Murray J, Byrne BJ, Shacham S, Al-Mousily F (2010). „PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats”. The Journal of Pharmacology and Experimental Therapeutics. 334 (2): 364—72. PMID 20430844. doi:10.1124/jpet.109.165001.
Svejda B, Kidd M, Giovinazzo F, Eltawil K, Gustafsson BI, Pfragner R, Modlin IM (2010). „The 5-HT(2B) receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment”. Cancer. 116 (12): 2902—12. PMID 20564397. doi:10.1002/cncr.25049.